Med BioGene Inc
Med BioGene Inc. (MBI: TSX Venture) is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests.The company develops gene expression assays (lab tests that examine organic samples on a molecular level) used to examine cancerous tumors. Its primary offering, LungExpress DX, is a late-stage assay candidate used to test lung cancer tumors in order to assist physicians in determining treatment options for their patients. The biotech firm's pipeline also contains similar methods for testing lymphoma and cardiovascular disease. Med BioGene filed for a US IPO in 2010, but fell short of funding and announced plans to review strategic alternatives later that year, including a possible sale or liquidation of the company.
Contact Details
Office Address
Med BioGene Inc
Gerald McGavin Bldg, Ste. 300
2386 East Mall
Vancouver, British Columbia, CANADA V6T 1Z3
Phone: 604-827-5100
Fax: 604-827-5120
Executives
Chairman
John H. Rayson
CEO and Director
Erinn B. Broshko